Pazopanib
- Generic Name
- Pazopanib
- Brand Names
- Votrient
- Drug Type
- Small Molecule
- Chemical Formula
- C21H23N7O2S
- CAS Number
- 444731-52-6
- Unique Ingredient Identifier
- 7RN5DR86CK
Overview
Pazopanib is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. It is developed by GlaxoSmithKline and was FDA approved on October 19, 2009.
Background
Pazopanib is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. It is developed by GlaxoSmithKline and was FDA approved on October 19, 2009.
Indication
Treatment of advanced renal cell cancer and advanced soft tissue sarcoma (in patients previously treated with chemotherapy)
Associated Conditions
- Advanced Renal Cell Carcinoma
- Advanced Soft Tissue Sarcoma
- Advanced Thyroid cancer
Clinical Trials
FDA Approved Products
Pazopanib
Manufacturer:Golden State Medical Supply, Inc.
Route:ORAL
Strength:200 mg in 1 1
Approved: 2024/03/21
NDC:51407-872
Pazopanib
Manufacturer:SUN PHARMACEUTICAL INDUSTRIES, INC.
Route:ORAL
Strength:200 mg in 1 1
Approved: 2023/10/20
NDC:63304-116
VOTRIENT
Manufacturer:Novartis Pharmaceuticals Corporation
Route:ORAL
Strength:200 mg in 1 1
Approved: 2023/05/10
NDC:0078-0670
Pazopanib
Manufacturer:Apotex Corp.
Route:ORAL
Strength:200 mg in 1 1
Approved: 2024/02/28
NDC:60505-4779
VOTRIENT
Manufacturer:Novartis Pharmaceuticals Corporation
Route:ORAL
Strength:200 mg in 1 1
Approved: 2023/05/10
NDC:0078-1077
Singapore Approved Products
TYROKA FILM-COATED TABLETS 200 MG
Manufacturer:Lotus Pharmaceutical Co., Ltd Nantou Plant
Form:TABLET, FILM COATED
Strength:200mg
Online:Yes
Approved: 2023/03/09
Approval:SIN16736P
Votrient Tablet 200 mg
Manufacturer:Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations), Glaxo Wellcome, S.A. (Primary and Secondary Packager), Siegfried Barbera, S.L., Lek Pharmaceuticals d.d.
Form:TABLET, FILM COATED
Strength:200 mg
Online:Yes
Approved: 2011/09/23
Approval:SIN14022P
Votrient Tablet 400 mg
Manufacturer:Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations), Glaxo Wellcome, S.A. (Primary and Secondary Packager), Siegfried Barbera, S.L., Lek Pharmaceuticals d.d.
Form:TABLET, FILM COATED
Strength:400 mg
Online:Yes
Approved: 2011/09/23
Approval:SIN14023P
PAZOPANIB-TEVA FC TABLETS 200 MG
Manufacturer:PharOS MT Ltd
Form:TABLET, FILM COATED
Strength:200 mg
Online:Yes
Approved: 2024/05/08
Approval:SIN17000P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath